ARCHIVES

FASEB Calls For 15% Increase For NIH Next Fiscal Year.

This article is from The Cancer Letter archive.

Vol. 27 No. 04 | January 26, 2001

Download PDF Visit The Full Archive

Related Articles

FDA Expands Nexavar Indication To Include Thyroid Cancer

December 27, 2013

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

May 9, 2003

NCI Considering Adoption Of NIGMS Guidelines To Limit Growth Of Renewals, Ensure New Grants

November 30, 1990

Indoor Tanning Industry Funded Author Of NEJM Review On Vitamin D Deficiency.

April 18, 2008

Conferees Agree On Extension Of Biomedical Research Authorities For Two Years; Kennedy-Waxman Bills Are Dead

November 28, 1980

Gori Tells McGovern Committee Diet Causes Major Share Of Cancer

August 6, 1976